Last reviewed · How we verify

NCT06222398

Exoskeleton Use With In Home Functional Activities

Terminated Last updated 22 January 2026
What this trial tests

trial testing Exoskeleton in Paraplegia in 12 participants. Terminated before completion.

Timeline
10 February 2024
Primary endpoint
28 December 2025
28 December 2025

Quick facts

Lead sponsorA.T. Still University of Health Sciences
StatusTerminated
Study typeOBSERVATIONAL
Enrollment12
Start date10 February 2024
Primary completion28 December 2025
Estimated completion28 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

A.T. Still University of Health Sciences

Who can join

18 and older, any sex, with Paraplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased independence. This is a pilot study to fine-tune the methods and to determine the feasibility of doing this study on a larger scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exoskeleton

Trials testing the same drug.

Other recruiting trials for Paraplegia

Currently open trials in the same condition.

Other A.T. Still University of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06222398.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing